SX-682
A Phase 1, Open-Label, Dose-Escalation With Expansion Study of SX-682 Alone and in Combination With Oral or Intravenous Decitabine in Subjects With Myelodysplastic Syndrome
Arms / Cohorts
Experimental:Dose Escalation: SX-682
Accepting patients
Experimental:Dose Expansion: SX-682
Accepting patients
Experimental:Dose Expansion: SX-682
Accepting patients
Experimental:Dose Expansion: SX-682 + Decitabine
Accepting patients
Experimental:Dose Expansion: SX-682 + Decitabine
Accepting patients
Experimental:Dose Expansion: SX-682
Accepting patients
Experimental:Dose Expansion: SX-682 + Decitabine
Accepting patients
Experimental:Dose Expansion: SX-682 + Decitabine
Accepting patients
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print a patient-friendly report to share with your patient.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.